Literature DB >> 11767799

Factors influencing patients' decisions to decline cancer genetic counseling services.

K P Geer1, M E Ropka, W F Cohn, S M Jones, S Miesfeldt.   

Abstract

Little is known about the factors influencing patients' decisions about whether to utilize cancer genetic counseling services. The purpose of this study is to identify potential barriers to broad utilization of such services. Of a total of 136 decliners of cancer genetic counseling services at our institution, 117 were deemed eligible to participate. Of these, 73 were randomly selected for study. A total of 37/73 (51%) agreed to participate in a semistructured telephone survey designed to assess the factors that impacted their decisions to decline cancer genetic counseling. An interview script, composed of both closed- and open-ended questions was used to direct the survey. Interviews were audiotaped. Responses to open-ended questions were content analyzed. Of the participants, 34 were female and 36 were Caucasian. Seventy-two percent of the participants were between ages 36 and 55 years. Participants cited the following reasons for choosing not to proceed with cancer genetic counseling: concern over health insurability for self or family (n=15); cost (n=12); emotional impact on self or family (n=11); no perceived benefit (n=11); and time commitment (n=9). These data provide an understanding of patient's attitudes and concern impacting their decisions to decline cancer genetic counseling. This information provides guidance for the development of interventions designed to limit barriers among patients referred for such services.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  2001        PMID: 11767799     DOI: 10.1023/a:1009451213035

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  29 in total

1.  Genetic testing of families with hereditary diseases.

Authors:  O I Olopade
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

Review 2.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Authors:  W Burke; M Daly; J Garber; J Botkin; M J Kahn; P Lynch; A McTiernan; K Offit; J Perlman; G Petersen; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-26       Impact factor: 56.272

3.  A descriptive study of BRCA1 testing and reactions to disclosure of test results.

Authors:  H T Lynch; S J Lemon; C Durham; S T Tinley; C Connolly; J F Lynch; J Surdam; E Orinion; S Slominski-Caster; P Watson; C Lerman; P Tonin; G Lenoir; O Serova; S Narod
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

4.  Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

Authors: 
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

Review 5.  Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.

Authors:  G Geller; J R Botkin; M J Green; N Press; B B Biesecker; B Wilfond; G Grana; M B Daly; K Schneider; M J Kahn
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

Review 6.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

7.  Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.

Authors:  L G Bluman; B K Rimer; D A Berry; N Borstelmann; J D Iglehart; K Regan; J Schildkraut; E P Winer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

8.  Genetic testing for breast-ovarian cancer susceptibility: a regional trial.

Authors:  S Loader; J C Levenkron; P T Rowley
Journal:  Genet Test       Date:  1998

9.  Attitudes about genetic testing for breast-ovarian cancer susceptibility.

Authors:  C Lerman; M Daly; A Masny; A Balshem
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

10.  Women's receptivity to testing for a genetic susceptibility to breast cancer.

Authors:  H Chaliki; S Loader; J C Levenkron; W Logan-Young; W J Hall; P T Rowley
Journal:  Am J Public Health       Date:  1995-08       Impact factor: 9.308

View more
  33 in total

1.  Genetic counseling for personal genomic testing: optimizing client uptake of post-test telephonic counseling services.

Authors:  Elissa Levin; Sara Riordan; Jana Klein; Shannon Kieran
Journal:  J Genet Couns       Date:  2012-04-28       Impact factor: 2.537

2.  Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.

Authors:  Larissa A Meyer; Meaghan E Anderson; Robin A Lacour; Anuj Suri; Molly S Daniels; Diana L Urbauer; Graciela M Nogueras-Gonzalez; Kathleen M Schmeler; David M Gershenson; Karen H Lu
Journal:  Obstet Gynecol       Date:  2010-05       Impact factor: 7.661

Review 3.  Global trends on fears and concerns of genetic discrimination: a systematic literature review.

Authors:  Annet Wauters; Ine Van Hoyweghen
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

4.  Exploring the concept of genetic discrimination.

Authors:  Margaret Otlowski
Journal:  J Bioeth Inq       Date:  2005       Impact factor: 1.352

5.  Increasing utilization of cancer genetic counseling services using a patient navigator model.

Authors:  Alanna Kulchak Rahm; Anna Sukhanova; Jennifer Ellis; Judy Mouchawar
Journal:  J Genet Couns       Date:  2007-04       Impact factor: 2.537

6.  Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.

Authors:  C Phelps; F Wood; P Bennett; K Brain; J Gray
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

7.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

8.  Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral.

Authors:  E van Riel; S van Dulmen; M G E M Ausems
Journal:  J Community Genet       Date:  2012-03-17

9.  Views of discrimination among individuals confronting genetic disease.

Authors:  Robert Klitzman
Journal:  J Genet Couns       Date:  2010-02       Impact factor: 2.537

10.  Withdrawal from genetic counselling for cancer.

Authors:  Eveline Bleiker; Gea Wigbout; Anja van Rens; Senno Verhoef; Laura Van't Veer; Neil Aaronson
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.